On February 25, 2025 Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, reported that senior management will participate in TD Cowen 45th Annual Health Care Conference and Leerink Partners Global Healthcare Conference 2025 (Press release, Alterome Therapeutics, FEB 25, 2025, View Source [SID1234650515]). Members of Alterome management will participate in one-on-one investor meetings at both conferences. Details of participation are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
TD Cowen 45th Annual Health Care Conference
Date: March 3
Location: Boston, MA
Leerink Partners Global Healthcare Conference 2025
Date: March 10
Location: Miami, FL